Active06828501Private limited companyGodalming

ASPIRE PHARMA LIMITED

Significant control: Aphl 2 Limited (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Aspire Pharma Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Aspire Pharma Limited sell?

Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

ASPIRE PHARMA LIMITED is an active private limited company (company number 06828501) incorporated on 24 February 2009, registered in Godalming. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest full accounts cover the period ending 31 December 2025, showing net assets of £87.62m and cash of £7.03m, with 114 employees on average. Net assets rose 33% on the prior period (£65.80m).

Peer position · net assets

By net assets it sits in the top quarter of 50 comparable companies in Surrey (median £3,179, upper quartile £541k).

02

Ownership and control

1 active · 2 other
  • Aphl 2 Limited
    corporate entity, England And Wales · since 19 September 2019
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Aspire Pharma Holdings Limited
    corporate entity · since 6 April 2016 · ceased 4 September 2019
    • owns 75–100% of shares
  • Aphl 1 Limited
    corporate entity, England And Wales · since 4 September 2019 · ceased 19 September 2019
    • owns 75–100% of shares
    • holds 75–100% of voting rights

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
24 February 200917 yrs ago
Next accounts due
30 September 2027in 340 days
Confirmation statement due
10 March 2027in 136 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 46460
Wholesale of pharmaceutical goods
Accounts type
Full
Size band
MediumCompanies Act thresholds
05

Financials

3 periods on record · latest ending 31 December 2025
Net assets
£87.62m
+33%vs Dec 2024
Cash at bank
£7.03m
−17%vs Dec 2024
Turnover
Not reported
Employees
114
+14%vs Dec 2024
Net assets
£87.62m
Cash at bank
£7.03m
Profit for the year
£21.82m
Average employees
114
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2025£87.62m£7.03m—£34.45m—£21.82m114
31 December 2024£65.80m£8.51m—£29.46m—£23.09m100
31 December 2023———————
Current ratio2.32Current assets ÷ creditors within one year
Cash per employee£62kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £87,624,000 at 31 December 2025
  • Net assets up 10% or more on the prior period+33.2% vs prior period
  • Current assets at least 1.5× creditors within one yearCurrent ratio 2.32
  • Cash at bank of £50,000 or moreCash £7,034,000
  • Three or more accounting periods on record3 periods on record
  • Incorporated five or more years agoIncorporated 24 February 2009

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 340 days
  2. Confirmation statement duein 136 days
  3. Accounts period endNet assets £87.62m · full accounts
  4. Accounts period endNet assets £65.80m · full accounts
  5. Accounts period end
  6. Incorporated
08

Similar companies in Surrey

Same activity (wholesale of pharmaceutical goods), closest in incorporation date
09

Reminders for ASPIRE PHARMA LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.